Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the Earnings Conference Call is scheduled to be held on Monday, May 16, 2022 at 4.00 p.m. IST for analysts/ investors to discuss the Q4 & FY22 results. Neogen Chemicals Ltd - 542665 - Board to consider Final Dividend
Neogen Chemicals Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 14, 2022, inter-alia, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2022 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2022 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting. Further, vide company''s letter dated March 31, 2022, the trading window closure period has commenced from April 01, 2022 and will end 48 hours after the declaration of Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2022 pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. Neogen Chemicals Ltd - 542665 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2022 ,inter alia, to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, May 14, 2022, inter-alia, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2022 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2022 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting. Neogen Chemicals Ltd - 542665 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNeogen Chemicals Ltd 2CINL24200MH1989PLC050919 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 149.19 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Unnati Kanani Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Ketan Vyas Designation: Chief Financial Officer EmailId: [email protected] Date: 15/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Neogen Chemicals Ltd - 542665 - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Financial Year Ended March 31, 2022.
Pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we are enclosing herewith the certificate issued to Neogen Chemicals Limited in respect of aforesaid Regulation by DVD & Associates, Practicing Company Secretaries, Pune for the financial year ended March 31, 2022. Neogen Chemicals Ltd - 542665 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Unnati KananiDesignation :- Company Secretary and Compliance Officer Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the management of Neogen Chemicals Limited will be participating in Axis Capital Chemical Conference on Tuesday, March 29, 2022. The discussion will be under the purview of Neogen Chemicals' Q39MFY22 Earnings Presentation which has already been uploaded on the websites of BSE Limited and National Stock Exchange of India Limited and also on the Company's website www.neogenchem.com Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the management of Neogen Chemicals Limited will be participating in Axis Capital Chemical Conference on March 28, 2022. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the management of Neogen Chemicals Limited will be participating in for Ambit''s Chemicals CXO Conclave on February 23, 2022. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
With reference to the captioned subject, please find enclosed herewith the Earnings Call Transcript of the Company's Q3FY22 Earnings Conference Call held on Monday, January 31, 2022.